Weight change from incretin-based weight loss medications across categories of second-generation antipsychotics
Semaglutide and tirzepatide induce weight loss among those prescribed SGAs, with lower effectiveness in those prescribed higher AIWG SGAs.
Authors
- Vasanth Ravikumar (ORCID: https://orcid.org/0000-0002-8959-3214)
- Robert O. Cotes (ORCID: https://orcid.org/0000-0001-9903-8807)
- David Goldsmith (ORCID: https://orcid.org/0000-0002-4349-9193)
- Francisco J. Pasquel (ORCID: https://orcid.org/0000-0002-3845-6703)
- Jithin Sam Varghese (ORCID: https://orcid.org/0000-0003-3825-9897)
- Mohammed K. Ali (ORCID: https://orcid.org/0000-0001-7266-2503)
Institutions
- Emory University (US)
- Office of the National Coordinator for Health Information Technology (US)
- Woodruff Health Sciences Center (US)
Publication Details
- Journal
- International Journal of Obesity
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1038/s41366-025-01885-4
- Citations
- 1
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- National Institutes of Health